Organic-Vaccines, a company specializing in using biotechnology to utilize a patient’s own cells for treatments, recently applied to the World Health Organization (WHO) for compassionate use of the company’s MERS-CoV (Middle-East Respiratory Syndrome Coronavirus) vaccine.

Organic-Vaccines wants to fully develop its MERS-CoV vaccine before the spring. Camels, which most health professionals agree are MERS carriers, give birth in the spring. Finalizing the vaccine before the newborns arrive may be key to preventing more MERS-CoV cases.